LeadScope: Software for Exploring Large Sets of Screening Data

Modern approaches to drug discovery have dramatically increased the speed and quantity of compounds that are made and tested for potential potency. The task of collecting, organizing, and assimilating this information is a major bottleneck in the discovery of new drugs. We have developed LeadScope a novel, interactive computer program for visualizing, browsing, and interpreting chemical and biological screening data that can assist pharmaceutical scientists in finding promising drug candidates. The software organizes the chemical data by structural features familiar to medicinal chemists. Graphs are used to summarize the data, and structural classes are highlighted that are statistically correlated with biological activity.

[1]  J N Weinstein,et al.  Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity. , 1998, Molecular pharmacology.

[2]  Stephen H. Friend,et al.  Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues , 1998 .

[3]  Robert P. Sheridan,et al.  Chemical Similarity Using Physiochemical Property Descriptors , 1996, J. Chem. Inf. Comput. Sci..

[4]  Ting Wang,et al.  3DFS: A New 3D Flexible Searching System for Use in Drug Design , 1998, J. Chem. Inf. Comput. Sci..

[5]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[6]  David J. Cummins,et al.  Molecular Diversity in Chemical Databases: Comparison of Medicinal Chemistry Knowledge Bases and Databases of Commercially Available Compounds , 1996, J. Chem. Inf. Comput. Sci..

[7]  Steven L. Teig,et al.  Chemical Function Queries for 3D Database Search , 1994, J. Chem. Inf. Comput. Sci..

[8]  M. Boyd,et al.  Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .

[9]  Robert E. Stobaugh.  Chemical substructure searching , 1985, J. Chem. Inf. Comput. Sci..

[10]  Roderick E. Hubbard,et al.  Characterising the geometric diversity of functional groups in chemical databases , 1995, J. Comput. Aided Mol. Des..

[11]  Xin Chen,et al.  Recursive Partitioning Analysis of a Large Structure-Activity Data Set Using Three-Dimensional Descriptors1 , 1998, J. Chem. Inf. Comput. Sci..

[12]  R. McGuire,et al.  Principal components describing biological activities and molecular diversity of heterocyclic aromatic ring fragments. , 1996, Journal of medicinal chemistry.

[13]  D. Hawkins,et al.  Analysis of a Large Structure‐Activity Data Set Using Recursive Partitioning , 1997 .

[14]  Steven F. Roth,et al.  Toward an information visualization workspace: combining multiple means of expression , 1997 .

[15]  David Weininger,et al.  Stigmata: An Algorithm To Determine Structural Commonalities in Diverse Datasets , 1996, J. Chem. Inf. Comput. Sci..

[16]  Toshikazu Oki,et al.  Overview Oncologic, Endocrine & Metabolic: Oncologic, Endocrine & Metabolic :Ellipticine and related anticancer agents , 1996 .

[17]  R. Venkataraghavan,et al.  Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..

[18]  J N Weinstein,et al.  Neural computing in cancer drug development: predicting mechanism of action. , 1992, Science.

[19]  Robert P. Sheridan,et al.  A Method for Visualizing Recurrent Topological Substructures in Sets of Active Molecules , 1998, J. Chem. Inf. Comput. Sci..

[20]  P Willett,et al.  SLASH: a program for analysing the functional groups in molecules. , 1998, Journal of molecular graphics & modelling.

[21]  Robert D. Brown.  Descriptors for diversity analysis , 1996 .

[22]  H. Matter,et al.  Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors. , 1997, Journal of medicinal chemistry.

[23]  Kurt Varmuza,et al.  Substructure Isomorphism Matrix , 2000, J. Chem. Inf. Comput. Sci..

[24]  Michael Wiese,et al.  QSAR and Molecular Modelling of Catamphiphilic Drugs Able to Modulate Multidrug Resistance in Tumors , 1997 .

[25]  Yvonne C. Martin,et al.  Use of Structure-Activity Data To Compare Structure-Based Clustering Methods and Descriptors for Use in Compound Selection , 1996, J. Chem. Inf. Comput. Sci..

[26]  Ben Shneiderman,et al.  Visual information seeking: tight coupling of dynamic query filters with starfield displays , 1994, CHI '94.

[27]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[28]  Michael M. Hann,et al.  RECAP — Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry. , 1998 .

[29]  D A Scudiero,et al.  The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. , 1997, Anti-cancer drug design.